Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123804784 | 12380478 | 4 | F | 20160726 | 20160518 | 20160811 | PER | US-PFIZER INC-2016248679 | PFIZER | 55.00 | YR | M | Y | 0.00000 | 20160811 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123804784 | 12380478 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, 1 CAPSULE ONCE DAILY FOR 28 DAYS ON, THEN 2 WEEKS OFF, THEN REPEAT | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 123804784 | 12380478 | 2 | C | IRON | IRON | 1 | UNK | 0 | |||||||||||
| 123804784 | 12380478 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 123804784 | 12380478 | 4 | C | PROBIOTICS | PROBIOTICS NOS | 1 | UNK | 0 | |||||||||||
| 123804784 | 12380478 | 5 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 | |||||||||||
| 123804784 | 12380478 | 6 | C | ADVIL | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 123804784 | 12380478 | 7 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | 0 | |||||||||||
| 123804784 | 12380478 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 123804784 | 12380478 | 9 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123804784 | 12380478 | 1 | Renal cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123804784 | 12380478 | Back pain | |
| 123804784 | 12380478 | Blood potassium decreased | |
| 123804784 | 12380478 | Chest discomfort | |
| 123804784 | 12380478 | Disease progression | |
| 123804784 | 12380478 | Dyspnoea | |
| 123804784 | 12380478 | Fatigue | |
| 123804784 | 12380478 | Hyperhidrosis | |
| 123804784 | 12380478 | Nasopharyngitis | |
| 123804784 | 12380478 | Nausea | |
| 123804784 | 12380478 | Pyrexia | |
| 123804784 | 12380478 | Renal cancer metastatic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |